Maxcyte (MXCT) Raw Materials (2020 - 2026)

Maxcyte (MXCT) has 7 years of Raw Materials data on file, last reported at $3.5 million in Q1 2026.

• On a quarterly basis, Raw Materials fell 21.82% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $3.5 million, a 21.82% decrease from a year earlier, with the FY2025 full-year figure at $3.9 million, down 18.08% from the prior year.
• Raw Materials for Q1 2026 stood at $3.5 million, down from $3.9 million in the prior quarter.
• Over the last five years, Raw Materials for MXCT reached as high as $6.0 million in Q1 2023 and fell as low as $3.5 million in Q1 2026.
• Historically, Raw Materials has averaged $4.9 million across 5 years, with a median of $5.2 million in 2022.
• Across the five-year window, Raw Materials soared 224.18% in 2022 and slumped 30.53% in 2025, its largest moves.
• Year by year, Raw Materials stood at $5.7 million in 2022, then grew by 0.76% to $5.7 million in 2023, then retreated by 17.16% to $4.7 million in 2024, then decreased by 18.08% to $3.9 million in 2025, then fell by 9.6% to $3.5 million in 2026.
• Per Business Quant data, the three most recent Raw Materials figures were $3.5 million in Q1 2026, $3.9 million in Q4 2025, and $3.9 million in Q3 2025.